Market Indices
Latest News
 |
Key Points- Pomerantz Law Firm investigates claims on behalf of investors...March 10, 2026 NVO -2.65% |
| ||
| ||
| ||
|
Price Targets
Akash Tewari from Jefferies issued a price target of $138.00 for BNTX on 2026-03-10 19:41:00.The adjusted price target was set to $138.00.At the time of the announcement, BNTX...
March 10, 2026 BNTX -17.85%
Asthika Goonewardene from Truist Financial issued a price target of $155.00 for BNTX on 2026-03-10 18:28:00.The adjusted price target was set to $155.00.At the time of the announcement,
March 10, 2026 BNTX -17.85%
from Morgan Stanley issued a price target of $128.00 for BNTX on 2026-03-10 16:29:00.The adjusted price target was set to $128.00.At the time of the announcement, BNTX...
March 10, 2026 BNTX -17.85%
Asthika Goonewardene from Truist Financial issued a price target of $70.00 for LEGN on 2026-03-10 16:10:00.The adjusted price target was set to $70.00.At the time of the announcement,
March 10, 2026 LEGN 2.24%
Cui Cui from Jefferies issued a price target of $69.00 for LEGN on 2026-03-10 16:01:00.The adjusted price target was set to $69.00.At the time of the announcement, LEGN...
March 10, 2026 LEGN 2.24%
Annual/Quarterly Reports Summary
Summit Therapeutics Inc. (SMMT) Quarterly Report: What Does It Reveal About Their Sector Performance
May 1, 2025 SMMT 3.78%
In a landscape of rising revenues and increasing operational costs, the company navigates challenges with a focus on innovation and sustainability. Despite a dip in net income and profit declines...
February 5, 2025 TEVA -0.25%
In a year marked by resilience, the company celebrated record revenues of $25 billion, driven by strong ticket sales and operational efficiency. With a focus on North America, it reduced...
January 27, 2025 CUK -0.50%